Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (ACS) https://kusajili.fr:443/Trial/Hv9vqR2UTkSOnnluWCo3Mg%24a-phase-iii-double-blind-randomized-placebo-controlled-study-to-evaluate-the-effects-of-dalcetrapib-on-cardiovascular-cv-risk-i
I have read and accept the terms of use of the site and the Privacy Policy
Send your message